Grantham, Mayo, Van Otterloo & Co (GMO)’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $794M | Sell |
|
|||||
|
2025
Q1 | $939M | Buy |
|
|||||
|
2024
Q4 | $738M | Buy |
|
|||||
|
2024
Q3 | $876M | Buy |
|
|||||
|
2024
Q2 | $731M | Buy |
|
|||||
|
2024
Q1 | $647M | Buy |
|
|||||
|
2023
Q4 | $433M | Buy |
|
|||||
|
2023
Q3 | $387M | Buy |
|
|||||
|
2023
Q2 | $369M | Buy |
|
|||||
|
2023
Q1 | $330M | Buy |
|
|||||
|
2022
Q4 | $364M | Sell |
|
|||||
|
2022
Q3 | $324M | Sell |
|
|||||
|
2022
Q2 | $352M | Sell |
|
|||||
|
2022
Q1 | $458M | Sell |
|
|||||
|
2021
Q4 | $511M | Sell |
|
|||||
|
2021
Q3 | $426M | Buy |
|
|||||
|
2021
Q2 | $399M | Buy |
|
|||||
|
2021
Q1 | $372M | Buy |
|
|||||
|
2020
Q4 | $329M | Sell |
|
|||||
|
2020
Q3 | $277M | Buy |
|
|||||
|
2020
Q2 | $267M | Buy |
|
|||||
|
2020
Q1 | $230M | Buy |
|
|||||
|
2019
Q4 | $295M | Sell |
|
|||||
|
2019
Q3 | $242M | Buy |
|
|||||
|
2019
Q2 | $268M | Buy |
|
|||||
|
2019
Q1 | $233M | Sell |
|
|||||
|
2018
Q4 | $244M | Sell |
|
|||||
|
2018
Q3 | $282M | Sell |
|
|||||
|
2018
Q2 | $265M | Sell |
|
|||||
|
2018
Q1 | $278M | Buy |
|
|||||
|
2017
Q4 | $215M | Sell |
|
|||||
|
2017
Q3 | $194M | Sell |
|
|||||
|
2017
Q2 | $206M | Buy |
|
|||||
|
2017
Q1 | $105M | Sell |
|
|||||
|
2016
Q4 | $101M | Sell |
|
|||||
|
2016
Q3 | $97.7M | Sell |
|
|||||
|
2016
Q2 | $148M | Buy |
|
|||||
|
2016
Q1 | $155M | Buy |
|
|||||
|
2015
Q4 | $126M | Buy |
|
|||||
|
2015
Q3 | $126M | Buy |
|
|||||
|
2015
Q2 | $106M | Buy |
|
|||||
|
2015
Q1 | $19.3M | Sell |
|
|||||
|
2014
Q4 | $28M | Sell |
|
|||||
|
2014
Q3 | $120M | Sell |
|
|||||
|
2014
Q2 | $161M | Sell |
|
|||||
|
2014
Q1 | $197M | Buy |
|
|||||
|
2013
Q4 | $149M | Buy |
|
|||||
|
2013
Q3 | $56.6M | Buy |
|
|||||
|
2013
Q2 | $34.2M | Buy |
|